Human gasdermin D and MLKL disrupt mitochondria, endocytic traffic and TORC1 signalling in budding yeast

Marta Valenti1, María Molina1, Víctor J Cid1

  • 1Departamento de Microbiología y Parasitología, Facultad de Farmacia, and Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), Universidad Complutense de Madrid, Madrid 28040, Spain.

Open Biology
|May 23, 2023
PubMed

Insights

Gasdermin D (GSDMD) and mixed lineage kinase domain-like protein (MLKL) disrupt yeast cell functions, including growth and organelle integrity. This study establishes a humanized yeast model for studying these cell death proteins and aiding drug discovery.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Gasdermin D (GSDMD) and mixed lineage kinase domain-like protein (MLKL) are key effectors in pyroptosis and necroptosis, respectively.
  • These proteins induce regulated cell death by disrupting plasma membrane integrity.
  • Budding yeast (Saccharomyces cerevisiae) serves as a model eukaryote for studying human disease-associated proteins via heterologous expression.

Purpose of the Study:

  • To characterize the cellular effects of GSDMD and its N-terminal domain (GSDMD(NT)) in yeast.
  • To compare the effects of GSDMD(NT) with those of MLKL in the same model system.
  • To establish a humanized yeast platform for studying GSDMD and MLKL functions and for drug discovery.

Main Methods:

  • Heterologous expression of GSDMD, GSDMD(NT), and MLKL in Saccharomyces cerevisiae.
  • Analysis of cellular effects including growth inhibition, aggregate formation, mitochondrial morphology, and cell cycle progression.
  • Investigation of TORC1 signaling pathway and vesicular trafficking (endosomal and autophagic).

Main Results:

  • Both GSDMD(NT) and MLKL inhibited yeast growth and formed cytoplasmic aggregates.
  • Mitochondrial fragmentation was observed, with loss-of-function GSDMD(NT) mutants showing organelle affinity.
  • Irreversible cell cycle arrest occurred via TORC1 inhibition, and both proteins disrupted vesicular traffic.

Conclusions:

  • GSDMD and MLKL induce significant cellular perturbations in yeast, mirroring aspects of their function in mammalian cells.
  • The study validates a humanized yeast model for investigating GSDMD and MLKL.
  • This platform is suitable for structure-function analyses and the screening of potential therapeutic compounds.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
14.7K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K